Drug Patents owned by Angelini Pharma

1. List of Oleptro drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8133893 ANGELINI PHARMA Trazodone and trazodone hydrochloride in purified form
Mar, 2029

(6 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7829120 ANGELINI PHARMA Trazodone composition for once a day administration
Mar, 2027

(4 years from now)

Drugs and Companies using TRAZODONE HYDROCHLORIDE ingredient

Market Authorisation Date: 02 February, 2010

Treatment: Method of treating depression

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of OLEPTRO before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic